Nipro Medical Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-02-16
Share capital
6,222,500.00 PLN
Registered address
Pańska 73, 00-834 Warszawa, Poland
Electronic delivery address
AE:PL-56229-79302-VACBB-19

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$108,620

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 76 days for 2020). All were audited by a statutory auditor.

  • 202512/06/2026
  • 202402/07/2025
  • 202316/07/2024
  • 202205/07/2023
  • 202125/07/2022
  • 202030/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods187 / 1,141
Top 16%
Division · Wholesale trade1,824 / 19,988
Top 9.1%
City · Warszawa2,743 / 56,967
Top 4.8%
Voivodeship · Mazowieckie3,749 / 77,130
Top 4.9%
Country · Poland13,013 / 297,932
Top 4.4%

Results vs industry

Revenue
This companyUSD 15.78mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 457.90kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 15.03mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 7.77mMedianUSD 609.81kAverageUSD 11.84m

Public procurement

148 tenders recorded as contractor: 82 national ($3,591,341) and 66 EU ($12,612,832).

SubjectAmount
Successive supply of renal dialysis products
–
Supply of medicines and medical devices divided into 11 lots
–
Supply of single-use dialysis equipment – bloodlines, HD and HX dialysers, filters for dialysis machines, and a closed system for handling and maintaining the patency of central dialysis access devices
–

Authorized Representatives

Agnieszka Wlazło – Attorney-in-fact (sole)
Serge K Kemps – Management Board Member
Wojciech Szekalski – Management Board Member

Manner of representation

Joint action by two members of the management board, or by one member of the management board together with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Nipro Medical Europe N.v.
124,450$1,680,848.19100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-10-31.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Sep 29, 2020Merger plan

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,065
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$16,484
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,728

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Centrala Farmaceutyczna CefarmS.A.
ITPS.A.
Ivoclar-Vivadent Polskasp. z o.o.
Medif sp. z o.o.sp. k.
IMC Impomed CentrumS.A.
Gtm-Mobil M-T T.Walisiewiczsp. k.
Reynolds Medicalsp. z o.o.
Petronafsp. z o.o.
CryoprofilS.A.
Novisc Pharmasp. z o.o.

Change history

DateEvent
2021-01-21Share capital increase
2018-12-12Name change
2017-07-04PKD change
2014-11-17Address change
2013-07-18Share capital increase

FAQ

Last updated: 2026-10-07